Clinical Translation
Clinical Translation Summary
Clinical Translation
Inquiries

Director, Clinical Translation

Dr. Teresa Petrocelli
tpetrocelli @oicr.on.ca

Clinical Translation works to bring scientific innovations in detecting, diagnosing and treating cancer to the patients who need them by bridging the gap between science and patient care.

What we do
Clinical Translation works to bring scientific innovations in detecting, diagnosing and treating cancer to the patients who need them by bridging the gap between science and patient care.

Why we do it
New knowledge doesn’t always result in new healthcare practices. There are many challenges that delay or prevent even the most exciting scientific research from being adopted into cancer care. By addressing these challenges and bridging these gaps, Clinical Translation helps patients benefit from research innovations sooner.

How we do it
We work with patients, clinicians, healthcare leaders and partners in government and industry to create a pathway for new cancer discoveries. We support clinical trials and other innovative studies that test new ways to detect and treat cancer earlier, when patients have the best chance at surviving and living well, and seek to implement new discoveries into Ontario’s healthcare system. We are especially focused on hard-to-treat cancers, where new approaches are the most needed.

Research Initiatives
Clinical Translation Pathway

Clinical Translation Pathway (CTP)

CTP supports practice-changing pre-clinical and clinical research in biomarkers, diagnostics and therapeutics that advance early detection and intervention research and have a clear path to clinical impact.Learn more about CTP

Window of Opportunity (WOO) Trials

Window of Opportunity (WOO) Trials

Window of Opportunity (WOO) Trials support pre-surgical trials focused on biomarker analysis of how new therapies or combinations of therapies affect tumour cells and immune cells in newly diagnosed, treatment naïve patients. Learn more about WOO Trials

Implementation Science

Implementation Science

Implementation Science enables OICR to bridge the gaps between research and its use in real world settings, especially clinical medicine, by establishing pathways to assess new tools and technologies.Learn more about Implementation Science

Networks
OHS

Ontario Health Study (OHS)

A landmark study with over 224,900 participants that is helping researchers better understand the environmental, lifestyle, and genetic factors that cause cancer and other chronic diseases.Learn more about OHS

3CTN

Canadian Cancer Clinical Trials Network (3CTN)

A pan-Canadian initiative to improve the efficiency and quality of clinical trials in Canada. Learn more about 3CTN

OCREB

Ontario Cancer Research Ethics Board (OCREB)

Ontario Cancer Research Ethics Board is an expert central oncology REB serving almost every hospital in Ontario that conducts cancer clinical trials. Learn more about OCREB

In the News
Longtime OICR Executives to lead Institute through important new chapter
Longtime OICR Executives to lead Institute through important new chapter
Nov 11, 2024
New 3CTN initiative aims to address barriers faced by underrepresented populations and expand clinical trial involvement
New 3CTN initiative aims to address barriers faced by underrepresented populations and expand clinical trial involvement
May 27, 2024
New “window-of-opportunity” clinical trials explore cutting-edge treatments for cancers of the liver, head and neck
New “window-of-opportunity” clinical trials explore cutting-edge treatments for cancers of the liver, head and neck
Apr 18, 2024
How the Ontario Cancer Research Ethics Board protects participants while streamlining research in the province
How the Ontario Cancer Research Ethics Board protects participants while streamlining research in the province
Mar 22, 2024
“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers
“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers
Feb 28, 2024
The secret to stopping deadly cancer recurrences may be in your blood
The secret to stopping deadly cancer recurrences may be in your blood
Aug 11, 2023
Ask a Cancer Researcher: What happens to samples donated to tumour banks?
Ask a Cancer Researcher: What happens to samples donated to tumour banks?
Jul 19, 2023
Navigating hope: Helping cancer patients find and enrol in clinical trials
Navigating hope: Helping cancer patients find and enrol in clinical trials
Nov 24, 2022
Prostate cancer trial aims to deliver shorter, more effective radiotherapy thanks to advanced imaging
Prostate cancer trial aims to deliver shorter, more effective radiotherapy thanks to advanced imaging
Aug 24, 2022
Genome sequencing delivers real-time results for hard-to-treat pancreatic cancer
Genome sequencing delivers real-time results for hard-to-treat pancreatic cancer
Jul 11, 2022
OICR, Intensity Therapeutics and The Ottawa Hospital to conduct Window of Opportunity clinical trial in early-stage breast cancer
OICR, Intensity Therapeutics and The Ottawa Hospital to conduct Window of Opportunity clinical trial in early-stage breast cancer
Mar 24, 2021